CN
CN
CN
1-22 of 192 result

NewslettersApr 11, 2025

Porton Newsletter - Q1 2025 Recap

Technical Enabling Services & Solutions Company Events ESG Marketing Activities

NewslettersApr 11, 2025

Porton Newsletter - March 2025 Recap

Technical Enabling Services & Solutions Company Events ESG Marketing Activities

NewslettersMar 06, 2025

Porton Newsletter - Jan. to Feb. 2025 Recap

Technical Enabling Technical Solutions for PROTAC Drugs Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform

Porton Newsletter | Q4 2024 Recap

NewslettersDec 19, 2024

Porton Newsletter | Q4 2024 Recap

Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian Porton Successfully Hosts Ceremony for New Modality Capacity Upgrade Drug Modalities: Innovative Services & Solutions from Porton Pharma

Porton Newsletter | Q3 2024 Recap

NewslettersOct 01, 2024

Porton Newsletter | Q3 2024 Recap

Biologics and Conjugates CDMO Services Tides CDMO Services Porton J-STAR Cutting-Edge Technologies

NewslettersJul 07, 2024

Porton Newsletter | Q2 2024 Recap

Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia. Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR. Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.

NewslettersMar 31, 2024

Porton Newsletter | Q1 2024 Recap

Porton PharmaTech (Slovenia)-B31 R&D Labs and Kilo lab Suites (non-GMP), expected to be completed in May 2024. New Facilities Will Be Ready in Porton USA / J-STAR Porton's Antibody and ADC GMP Pilot Manufactory Officially Operated

Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200